Literature DB >> 3728502

Leukocyte concentrations in discrimination of benign from malignant lung lesions.

S P Thomson, J F Kessler, T P Miller.   

Abstract

Malignant lung lesions are associated with significant changes in leukocyte concentrations. However, overlap of values between normal subjects and patients with cancer has limited the clinical utility of this determination. To decrease the overlap, 2,000 cells per differential determination were counted, and replicate automated cell counts were performed in blood samples obtained on different mornings between 7 and 9 A.M. Seventy-five patients who presented with undiagnosed lung lesions were analyzed. Benign and malignant lung lesions could be accurately distinguished by either relative granulocyte or lymphocyte counts. With 65.5 percent granulocytes as the cutoff, 86 percent of patients (38 of 44) proved to have lung cancer had higher values, and 97 percent of patients (30 of 31) with benign lesions had lower values. Likewise, with 28 percent lymphocytes as the cutoff, 87 percent of patients with lung cancer (39 of 44) had lower values, and 94 percent of patients (29 of 31) with benign disease had higher values. Relative monocyte counts were not different. Absolute leukocyte concentrations, although different for each group, had considerable overlap and thus were poor discriminators. These data suggest that precise analytical techniques and the use of relative leukocyte concentrations can improve the clinical utility of the leukocyte count as a discriminator of benign and malignant lung lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3728502     DOI: 10.1016/0002-9343(86)90662-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

Review 1.  Cancer-associated myeloproliferation: old association, new therapeutic target.

Authors:  Ryan A Wilcox
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

2.  Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer.

Authors:  Georg Holgersson; Martin Sandelin; Even Hoye; Stefan Bergström; Roger Henriksson; Simon Ekman; Jan Nyman; Martin Helsing; Signe Friesland; Margareta Holgersson; Kristina Lamberg Lundström; Christer Janson; Elisabet Birath; Charlotte Mörth; Thomas Blystad; Sven-Börje Ewers; Britta Löden; Michael Bergqvist
Journal:  Med Oncol       Date:  2012-05-08       Impact factor: 3.064

3.  [Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer].

Authors:  Prajwal Boddu; Dana Villlines; Mebea Aklilu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

Review 4.  Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.

Authors:  Bernardo L Rapoport; Helen C Steel; Annette J Theron; Teresa Smit; Ronald Anderson
Journal:  Molecules       Date:  2020-04-01       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.